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Abstract  
Introduction: Acute limb ischemia is a critical medical condition that can quickly become a life threat. 
Therapeutic modalities such as catheter-directed thrombolysis (CDT) have demonstrated various levels of 
efficacy in previous studies.  
Objective: This study presents the descriptive findings of a series of cases who presented with acute arterial 
thrombotic limb ischemia and underwent CDT.  
Methods: This was a cross-sectional single-hospital-based case series, in which all patients who were 
diagnosed with acute arterial thrombotic limb ischemia, and consequently underwent CDT during the one-
year study period were included.  Detailed baseline characteristics and clinical findings of the studied patients 
on presentation, after intervention and at one-year follow-up are presented.  
Results: A total of 21 patients with a mean age of 60.7±15.2 years, including 16 males (76.2%) were included. 
The initial technical and treatment success rates were 20 (95.2%) and 14 (66.7%), respectively. The 
amputation-free and the overall survival rates after the one-year follow-up were 15 (71.4%) and 17 (81%), 
respectively. Four patients (19%) developed complications, two (9.5%) of which were significant (pulmonary 
hemorrhage and intraventricular hemorrhage). Amputation was performed in 6 (28.6%) cases.  
Conclusion: In this study, the treatment success rate and the technical success rate were satisfactory. 
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INTRODUCTION
Acute limb ischemia is a limb-threatening 
condition, defined as a sudden decrease in limb 
perfusion. It could result from an embolus from a 
proximal source, an acute thrombosis overlying the 
atherosclerotic plaque, acute stent/graft 
thrombosis, arterial dissection, or direct trauma to 
an artery (1). Early diagnosis and treatment are 
critical, regardless of the treatment modality to 
prevent tissue loss. Thromboembolectomy and 
artery bypass grafting were the cornerstones of 
treatment for years (2). Later, other options, such 
as catheter-directed thrombolytic therapy (CDT), 
were introduced for this purpose (3, 4). CDT is a 
safe and effective alternative for surgical treatment 
in patients with viable ischemic limbs, but previous 
studies have demonstrated various levels of 
efficacy for it (5, 6).  
This study presents the descriptive findings of a 
series of cases who presented to the emergency 
department of a referral vascular surgery center 
with acute arterial thrombotic limb ischemia and 
underwent CDT. 
Methods 
Study design and setting 
This is a cross-sectional single-hospital-based case 
series conducted from 2015 to 2016 in Sina 
Hospital, Tehran, Iran. All patients received 
standard management based on latest guidelines, 
and conducting this study did not make any 
changes in this regard. The data were extracted, 
analyzed and presented anonymously. The study 
protocol was approved by ethics committee of 
Tehran University of Medical Sciences. 
Study population 
All patients who were diagnosed with acute 
thrombotic limb ischemia (acute, or acute on 
chronic) (ICD-10: I70.209), and consequently 
underwent CDT during the one-year study period 
were included. Patients who presented with tissue 
gangrene were excluded. Clues used to determine 
thrombotic limb ischemia were prolonged limb 
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pain (up to 2 or 3 days), more prolonged sensory or 
motor dysfunction (between 10 to 14 days), an 
underlying arterial disease (such as a history of 
claudication), elderly patients, ipsilateral leg 
pulselessness, and decreased or absent 
contralateral leg pulses. Previous endocarditis, 
atrial fibrillation rhythm in electrocardiogram 
(ECG), mitral stenosis, previously replaced cardiac 
valve, and having undergone surgical embolectomy 
were the clues in favor of embolic type limb 
ischemia, and ruled against the diagnosis of 
thrombotic type of acute limb ischemia. In addition 
to history taking and physical examination, the 
diagnosis of acute limb ischemia was confirmed by 
color Doppler ultrasound. It is not the gold 
standard but this modality is the best noninvasive 
procedure that has been done routinely. 
Intervention 
All the patients were managed by one vascular 
surgery team. Since all the occlusion sites were 
proximal of the femoral artery, the crossover 
catheterization method was applied for all patients. 
Catheters with multi-side-hole tip, EV3 
McNamara™ (MedicalEcart, Ireland), were used for 
the intervention, ranging from 10 to 40 cm in 
length. The sheath of used catheters was at least 5Fr, 
and the used guidewire was 35/1000 inch. All 
patients underwent control angiography on the 1st 
and 2nd day following the catheterization. 
Streptokinase or rTPA were the thrombolytic 
agents of choice. All the patients concurrently 
received unfractionated heparin 1000 units/hour 
(500 units via the crossed over catheter and 500 
units through systematic infusion), which was 
continued up to 96 hours. All patients were 
transferred to the intensive care unit (ICU) 
following the catheterization, and their 
prothrombin time (PT), partial thromboplastin 
time (PTT), and international normalized ratio 
(INR) were checked four times per day, and 
complete blood count (CBC) and fibrinogen level 
were also checked daily. Drug infusion was 
discontinued if fibrinogen level<100, PTT>100, a 
significant drop in hemoglobin (more than 3 g/dL), 
or active bleeding complications (such as 
gastrointestinal, vaginal, intracranial, or etc.) were 
observed. Given the "acute on chronic" condition, 
treatment success was defined as alleviation of the 
acute phase and return to the chronic/basic state. 
Data gathering 
Using a checklist, data including sex, age, 
underlying disease, drug history, smoking history, 
site of occlusion, etiology of occlusion, duration of 
symptom onset to hospital admission, results of 
intervention, and complications were gathered 
prospectively. Follow-up findings such as mortality 
and amputation were recorded 30 days, 6 months, 
and 1 year after the primary intervention. 
Data analysis 
Statistical analysis was performed using the 
Statistical Package for Social Sciences (SPSS 16, 
SPSS Inc., Chicago, US). Data are expressed as 
number (%) or mean ± standard deviation (SD). 
RESULTS 
Twenty-one patients were included 16 of whom 
(76.2%) were male; and the mean age of the 
patients was 60.76±15.27 years. The baseline 
characteristics and clinical findings of the studied 
patients on presentation, after intervention, and at 
one-year follow-up are all summarized in table 1. 
Based on the findings, hypertension (52.4%) was 
the most frequent underlying disease; 47.6% used 
aspirin and 42.9% used warfarin. Ten patients 
(47.6%) had a history of smoking.  
The mean time interval between limb-symptom-
onset to visit was 4.24 ±5.48 days in patients. The 
mean time interval between limb-pain-onset to 
visit and the mean time interval between sensory-
symptom-onset to visit were 11.1±4.4 and 1.7±2.3 
days, respectively. The most frequent symptoms 
were pain, pulselessness and limb coldness, 
respectively. 
The most frequent site of occlusion was superficial 
femoral artery (42.9%) and popliteal artery 
(38.1%), respectively. Arterial thrombosis was the 
most common cause of occlusion, which was 
observed in 17 patients (81%). 
We were able to cannulate the artery, insert 
therapeutic catheters into the artery, and inject the 
drug in 20 patients (95.2%). Due to technical 
problems, it was not possible to channel the vessel 
in one patient who later underwent endovascular 
procedure. 
Overall, CDT was successful in 14 patients (66.7%), 
whereas it failed in 7 patients (33.3%) and led to 
subsequent endovascular procedure or 
amputations. 
Seventeen patients (80.9%) survived 30 days 
without amputation and 4 patients (19%) 
underwent amputation within 1 month after 
intervention for whom the mean time from 
intervention until amputation was 4.50±1.76 days. 
At follow-up, two more patients had undergone 
amputation 6 to 12 months after primary CDT, due 
to appearance of gangrenous signs and no distal 
run off in arteries. 
Within 30 days after CDT, four patients (19%) died, 
all of whom were among those whose CDT had 
failed and led to amputation, and 17 patients (81%) 
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survived; No patient died thereafter within the 
one-year follow-up period. Complications were 
reported in 4 (19.0%) patients, including two 
patients with significant complications and two 
(9.5%) cases with minor ones (Table 1).  
DISCUSSION 
Successful CDT in our study refers to a medical 
treatment, which has transformed an “acute” or 
“acute on chronic” state to a chronic state and does 
not require re-intervention through angioplasty, 
stenting, or amputation. Among the successfully 
treated patients, the initial symptoms (coldness, 
pulse, paresthesia, pain) were generally improved, 
but the disorders were not entirely resolved due to 
the underlying chronic disease (3, 7). 
Generally, the treatment options for these patients 
include surgical thromboembolectomy, artery 
bypass grafting, percutaneous transluminal 
angioplasty, and CDT (2, 6). The choice of the most 
appropriate treatment option depends on the 
severity of ischemia, which determines the most 
appropriate course of management. 
Kashyap et al. reported that the mortality rate of 
intra-arterial thrombolysis was 6.0% (3). Rafael et 
al. showed a 10.1% mortality rate in patients with 
acute limb ischemia undergoing surgical therapy 
(8). Grip et al. reported that thrombolytic 
treatment success rate was 80% among patients 
with acute leg ischemia (9). Additionally, Darwood 
et al. concluded that there is no apparent difference 
in amputation and death rate between surgery and 
thrombolysis (10). Also, Berridge et al. stated that 
there is no considerable difference in mortality rate 
between surgery and thrombolysis as initial 
management methods. At the same time, they 
reported that CDT decreased the need for surgery 
without enhancing the risk of amputation or death 
in acute limb ischemia due to thromboembolism 
(11). It seems that CDT could be considered for 
patients with mild to moderate level of ischemia 
and patients who may not tolerate general 
anesthesia and surgical technique (12). 
In this study, we showed that thrombolytic 
treatment success rate was 66.7% for the studied 
patients. The highest success rate (90.2%) among 
studies was reported by Lukasiewicz et al (13). The 
treatment success rate in our study is close to that 
of Schjriver et al. (69%) and Limtunsturakul S et al. 
(65%) (14, 15). Byrne et al. reported that treatment 
success rate was 83.8% (16), and Schernthgner et 
al. reported it to be 63% in their studies (17).  
In the current study, amputation was performed in 
28.6% of the patients, which is relatively high 
compared to similar studies. The amputation rate 
was 17.5% in the study by Grip et al.  (9) and 18.1% 
in Byrne et al. study (16). The highest amputation 
rate was reported by Wongwanit et al., which was 
32.1% (18). 
The 30-day and amputation-free survival rates are 
the most important indices in our study, which 
were 81% and 71.4%, respectively. Accordingly, 
the mortality rate in our study was 19% within 30 
days, which is high compared to rates reported in 
other studies (9). However, it seems that the vast 
majority of deaths in the present study were 
Table 1: The baseline characteristics and clinical findings 
of the studied patients on presentation, after intervention, 
and at one-year follow up (n=21) 
Variable Number (%) 
Sex 
Male 16 (76.2) 
Female 5 (23.8) 
Underlying disease  
Diabetes mellitus 9 (42.9) 
Ischemic heart disease 9 (42.9) 
Hypertension 11 (52.4) 
Coronary artery disease 3 (14.3) 
Cerebrovascular disease 2 (9.5) 
Peripheral Vascular disease 9 (42.9) 
Drug history 
Warfarin 9 (42.9) 
Aspirin 10 (47.6) 
Losartan 8 (38.1) 
Metformin 8 (38.1) 
Glibenclamide 4 (19.0) 
Symptoms on admission 
Pain 19 (90.5) 
Pulselessness 16 (76.2) 
Paresthesia 10 (47.6) 
Limb coldness 16 (76.2) 
Pallor 15 (71.4) 
Claudication 5 (23.8) 
Occlusion site 
Superficial femoral artery 9 (42.9) 
Common femoral artery 2 (9.5) 
Popliteal artery 8 (38.1) 
Femoropopliteal segment 2 (9.5) 
Etiology 
Arterial thrombosis 17 (81) 
Stent thrombosis 2 (9.5) 
Graft thrombosis 1 (4.7) 
Aneurism thrombosis 1 (4.7) 
Amputation following intervention (month) 
< 1 4 (19) 
1-6 0 (0.0) 
6-12 2 (9.5) 
Mortality following intervention (month) 
< 1 4 (19.0) 
1-6 0 (0.0) 
6-12 0 (0.0) 
Developed complications 
Intraventricular hemorrhage 1 (4.0) 
Pulmonary hemorrhage 1 (4.7) 
Access point Hematoma 2 (9.5) 
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related to other factors such as older age and 
presence of diabetes mellitus (DM) and were not a 
direct complication of CDT. 
In general, the causes of CDT failure and 
amputation in our study can be divided into three 
categories: a group of patients who have suffered 
from prolonged thrombosis leading to the 
formation of an adhesive clot resulting in less 
penetration of thrombolytic drug, leading to failure 
of thrombolytic therapy. In another group of 
patients, drug administration was discontinued 
due to its side effects or hemorrhage in other sites. 
In our study this problem occurred in 2 patients. 
Thrombolytic therapy failed in a third group of 
patients due to lack of distal arterial runoff to the 
thrombus, which was clarified in control 
angiographies. According to some studies, CDT will 
be more successful when an arterial runoff exists 
distal to the thrombus (12, 13, 19).  
In the present study, 19% of patients developed 
complications, which were major in 2 (9.5%) cases 
(pulmonary embolism and intraventricular 
hemorrhage), and minor (access point hematoma) 
in the other 2 (9.5%). Wongwanit et al.  (18) 
reported significant complications in 18.9% of 
patients, including large hematomas in access point 
as well as life-threatening intracerebral 
hemorrhage. Schernthgner et al. (17) described 
significant and minor bleeding in 3.9% of CDT 
cases. Bleeding had occurred in up to 30.3% in a 
study by Grip (9), 0.4% of which were intracranial 
hemorrhage. In the study of Lukasiewicz et al. (13), 
22% of patients developed complications, the most 
common of which was hematoma (9.8%).  
CONCLUSIONS 
In this study, treatment success rate and the initial 
technical success rate were 66.7% and 95.2%, 
respectively, which are satisfactory. However, the 
recorded mortality and amputation rates were 
high compared to other studies. 
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